Found: 58
Select item for more details and to access through your institution.
Cetuximab Enhanced the Cytotoxic Activity of Immune Cells during Treatment of Colorectal Cancer.
- Published in:
- Cellular Physiology & Biochemistry (Karger AG), 2017, v. 44, n. 3, p. 1038, doi. 10.1159/000485404
- By:
- Publication type:
- Article
Simultaneous detection and characterization of toxigenic <italic>Clostridium difficile</italic> directly from clinical stool specimens.
- Published in:
- Frontiers of Medicine, 2018, v. 12, n. 2, p. 196, doi. 10.1007/s11684-017-0560-5
- By:
- Publication type:
- Article
Reactive cutaneous capillary endothelial proliferation in advanced hepatocellular carcinoma patients treated with camrelizumab: data derived from a multicenter phase 2 trial.
- Published in:
- Journal of Hematology & Oncology, 2020, v. 13, n. 1, p. 1, doi. 10.1186/s13045-020-00886-2
- By:
- Publication type:
- Article
Nutrition and metabolism status alteration in advanced hepatocellular carcinoma patients treated with anti-PD-1 immunotherapy.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Enterobacterial LPS-inducible LINC00152 is regulated by histone lactylation and promotes cancer cells invasion and migration.
- Published in:
- Frontiers in Cellular & Infection Microbiology, 2022, v. 12, p. 1, doi. 10.3389/fcimb.2022.913815
- By:
- Publication type:
- Article
Genome Sequence and Analysis of Peptoclostridium difficile Strain ZJCDC-S82.
- Published in:
- Evolutionary Bioinformatics, 2016, n. 12, p. 41, doi. 10.4137/EBO.S32476
- By:
- Publication type:
- Article
NKG2D discriminates diverse ligands through selectively mechano‐regulated ligand conformational changes.
- Published in:
- EMBO Journal, 2022, v. 41, n. 2, p. 1, doi. 10.15252/embj.2021107739
- By:
- Publication type:
- Article
Dynamic alterations of genome and transcriptome in KRAS G13D mutant CRC PDX model treated with cetuximab.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Disease characteristics and treatment patterns of Chinese patients with metastatic colorectal cancer: a retrospective study using medical records from China.
- Published in:
- 2020
- By:
- Publication type:
- journal article
GdClean: removal of Gadolinium contamination in mass cytometry data.
- Published in:
- Bioinformatics, 2021, v. 37, n. 24, p. 4787, doi. 10.1093/bioinformatics/btab537
- By:
- Publication type:
- Article
Residual refinement for interactive skin lesion segmentation.
- Published in:
- Journal of Biomedical Semantics, 2021, v. 12, n. 1, p. 1, doi. 10.1186/s13326-021-00255-z
- By:
- Publication type:
- Article
Colorectal cancer microbiome programs DNA methylation of host cells by affecting methyl donor metabolism.
- Published in:
- Genome Medicine, 2024, v. 16, n. 1, p. 1, doi. 10.1186/s13073-024-01344-1
- By:
- Publication type:
- Article
Prognostic Value of Perineural Invasion in Gastric Cancer: A Systematic Review and Meta-Analysis.
- Published in:
- PLoS ONE, 2014, v. 9, n. 2, p. 1, doi. 10.1371/journal.pone.0088907
- By:
- Publication type:
- Article
Over-expression of cathepsin B in hepatocellular carcinomas predicts poor prognosis of HCC patients.
- Published in:
- Molecular Cancer, 2016, v. 15, p. 1, doi. 10.1186/s12943-016-0503-9
- By:
- Publication type:
- Article
Real-Time Cell Analysis for Monitoring Cholera Toxin-Induced Human Intestinal Epithelial Cell Response.
- Published in:
- Current Microbiology, 2015, v. 70, n. 4, p. 536, doi. 10.1007/s00284-014-0752-z
- By:
- Publication type:
- Article
SAFFRON-104: a phase Ib/II study of sitravatinib alone or with tislelizumab in advanced hepatocellular carcinoma and gastric cancer/gastroesophageal junction cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 11, p. 1, doi. 10.1007/s00262-024-03806-2
- By:
- Publication type:
- Article
Long-term survivals of immune checkpoint inhibitors as neoadjuvant and adjuvant therapy in dMMR/MSI-H colorectal and gastric cancers.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 9, p. 1, doi. 10.1007/s00262-024-03764-9
- By:
- Publication type:
- Article
Construction of TME and Identification of crosstalk between malignant cells and macrophages by SPP1 in hepatocellular carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2022, v. 71, n. 1, p. 121, doi. 10.1007/s00262-021-02967-8
- By:
- Publication type:
- Article
Integrated analysis of single-cell RNA-seq and bulk RNA-seq unravels tumour heterogeneity plus M2-like tumour-associated macrophage infiltration and aggressiveness in TNBC.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 1, p. 189, doi. 10.1007/s00262-020-02669-7
- By:
- Publication type:
- Article
Anti–PD-1/PD-L1 Blockade Immunotherapy Employed in Treating Hepatitis B Virus Infection–Related Advanced Hepatocellular Carcinoma: A Literature Review.
- Published in:
- Frontiers in Immunology, 2020, v. 11, p. 1, doi. 10.3389/fimmu.2020.01037
- By:
- Publication type:
- Article
Genomic signatures reveal DNA damage response deficiency in colorectal cancer brain metastases.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41467-019-10987-3
- By:
- Publication type:
- Article
The Optimal Therapy after Progression on Immune Checkpoint Inhibitors in MSI Metastatic Gastrointestinal Cancer Patients: A Multicenter Retrospective Cohort Study.
- Published in:
- Cancers, 2022, v. 14, n. 20, p. 5158, doi. 10.3390/cancers14205158
- By:
- Publication type:
- Article
Large-scale identification of extracellular plant miRNAs in mammals implicates their dietary intake.
- Published in:
- PLoS ONE, 2021, v. 16, n. 9, p. 1, doi. 10.1371/journal.pone.0257878
- By:
- Publication type:
- Article
Prognostic significance of vascular endothelial growth factor immunohistochemical expression in gastric cancer: a meta-analysis.
- Published in:
- Molecular Biology Reports, 2012, v. 39, n. 10, p. 9473, doi. 10.1007/s11033-012-1812-8
- By:
- Publication type:
- Article
A Pathologically Friendly Strategy for Determining the Organ‐specific Spatial Tumor Microenvironment Topology in Lung Adenocarcinoma Through the Integration of snRandom‐seq and Imaging Mass Cytometry.
- Published in:
- Advanced Science, 2024, v. 11, n. 26, p. 1, doi. 10.1002/advs.202308892
- By:
- Publication type:
- Article
Pan‐Cancer Single‐Cell and Spatial‐Resolved Profiling Reveals the Immunosuppressive Role of APOE+ Macrophages in Immune Checkpoint Inhibitor Therapy.
- Published in:
- Advanced Science, 2024, v. 11, n. 23, p. 1, doi. 10.1002/advs.202401061
- By:
- Publication type:
- Article
A Phase 3 Study of Pembrolizumab versus Placebo for Previously Treated Patients from Asia with Hepatocellular Carcinoma: Health-Related Quality of Life Analysis from KEYNOTE-394.
- Published in:
- Liver Cancer (2235-1795), 2024, v. 13, n. 4, p. 389, doi. 10.1159/000535338
- By:
- Publication type:
- Article
Phase 2 Study of the PD-1 Inhibitor Serplulimab plus the Bevacizumab Biosimilar HLX04 in Patients with Previously Treated Advanced Hepatocellular Carcinoma.
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, n. 2, p. 1, doi. 10.1159/000526638
- By:
- Publication type:
- Article
Tislelizumab in Patients with Previously Treated Advanced Hepatocellular Carcinoma (RATIONALE-208): A Multicenter, Non-Randomized, Open-Label, Phase 2 Trial.
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, n. 1, p. 72, doi. 10.1159/000527175
- By:
- Publication type:
- Article
A Phase 2 Study of Camrelizumab for Advanced Hepatocellular Carcinoma: Two-Year Outcomes and Continued Treatment beyond First RECIST-Defined Progression.
- Published in:
- Liver Cancer (2235-1795), 2021, v. 10, n. 5, p. 500, doi. 10.1159/000516470
- By:
- Publication type:
- Article
A Phase 2 Study of Camrelizumab for Advanced Hepatocellular Carcinoma: Two-Year Outcomes and Continued Treatment beyond First RECIST-Defined Progression.
- Published in:
- Liver Cancer (2235-1795), 2021, v. 10, n. 5, p. 500, doi. 10.1159/000516470
- By:
- Publication type:
- Article
Interleukin‐33 as an early predictor of cetuximab treatment efficacy in patients with colorectal cancer.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 23, p. 8338, doi. 10.1002/cam4.4331
- By:
- Publication type:
- Article
Editorial: Immunotherapy in Hepatocellular Carcinoma.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
China special issue on gastrointestinal tumors‐Improved survival after multidisciplinary team decision for patients with advanced gastrointestinal cancer: A multicenter, noninterventional, controlled study.
- Published in:
- International Journal of Cancer, 2023, v. 153, n. 11, p. 1885, doi. 10.1002/ijc.34543
- By:
- Publication type:
- Article
TOD-CUP: a gene expression rank-based majority vote algorithm for tissue origin diagnosis of cancers of unknown primary.
- Published in:
- Briefings in Bioinformatics, 2021, v. 22, n. 2, p. 2106, doi. 10.1093/bib/bbaa031
- By:
- Publication type:
- Article
A randomised phase II study of second-line XELIRI regimen versus irinotecan monotherapy in advanced biliary tract cancer patients progressed on gemcitabine and cisplatin.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Predictive value of preoperative peripheral blood neutrophil/lymphocyte ratio for lymph node metastasis in patients of resectable pancreatic neuroendocrine tumors: a nomogram-based study.
- Published in:
- World Journal of Surgical Oncology, 2017, v. 15, p. 1, doi. 10.1186/s12957-017-1169-5
- By:
- Publication type:
- Article
A phase II study of biweekly S-1 and paclitaxel (SPA) as first-line chemotherapy in patients with metastatic or advanced gastric cancer.
- Published in:
- 2015
- By:
- Publication type:
- Report
Biweekly S-1 plus paclitaxel (SPA) as second-line chemotherapy after failure from fluoropyrimidine and platinum in advanced gastric cancer: a phase II study.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 3, p. 503, doi. 10.1007/s00280-014-2537-2
- By:
- Publication type:
- Article
Signaling pathway perturbation analysis for assessment of biological impact of cigarette smoke on lung cells.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-95938-z
- By:
- Publication type:
- Article
A naive Bayes algorithm for tissue origin diagnosis (TOD-Bayes) of synchronous multifocal tumors in the hepatobiliary and pancreatic system.
- Published in:
- International Journal of Cancer, 2018, v. 142, n. 2, p. 357, doi. 10.1002/ijc.31054
- By:
- Publication type:
- Article
Association of interleukin 18 gene promoter polymorphisms with HBV recurrence after liver transplantation in Han Chinese population.
- Published in:
- Hepatitis Monthly, 2011, v. 11, n. 6, p. 469
- By:
- Publication type:
- Article
Whole-exome sequencing reveals potential mechanisms of drug resistance to FGFR3-TACC3 targeted therapy and subsequent drug selection: towards a personalized medicine.
- Published in:
- BMC Medical Genomics, 2020, v. 13, n. 1, p. N.PAG, doi. 10.1186/s12920-020-00794-x
- By:
- Publication type:
- Article
Development and validation of a meta-learning-based multi-modal deep learning algorithm for detection of peritoneal metastasis.
- Published in:
- International Journal of Computer Assisted Radiology & Surgery, 2022, v. 17, n. 10, p. 1845, doi. 10.1007/s11548-022-02698-w
- By:
- Publication type:
- Article
Depiction of the genomic and genetic landscape identifies CCL5 as a protective factor in colorectal neuroendocrine carcinoma.
- Published in:
- British Journal of Cancer, 2021, v. 125, n. 7, p. 994, doi. 10.1038/s41416-021-01501-y
- By:
- Publication type:
- Article
Depiction of the genomic and genetic landscape identifies CCL5 as a protective factor in colorectal neuroendocrine carcinoma.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Effect of Reduced-Dose Capecitabine Plus Cetuximab as Maintenance Therapy for RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Clinical Trial.
- Published in:
- JAMA Network Open, 2020, v. 3, n. 7, p. e2011036, doi. 10.1001/jamanetworkopen.2020.11036
- By:
- Publication type:
- Article
Irinotecan hydrochloride liposome HR070803 in combination with 5-fluorouracil and leucovorin in locally advanced or metastatic pancreatic ductal adenocarcinoma following prior gemcitabine-based therapy (PAN-HEROIC-1): a phase 3 trial.
- Published in:
- Signal Transduction & Targeted Therapy, 2024, p. 1, doi. 10.1038/s41392-024-01948-4
- By:
- Publication type:
- Article
Oxaliplatin plus irinotecan vs irinotecan as second-line treatment in pancreatic cancer patients: a randomized–controlled open-label Phase II study.
- Published in:
- Gastroenterology Report, 2023, v. 11, p. 1, doi. 10.1093/gastro/goac088
- By:
- Publication type:
- Article
S100A9<sup>+</sup>CD14<sup>+</sup> monocytes contribute to anti-PD-1 immunotherapy resistance in advanced hepatocellular carcinoma by attenuating T cell-mediated antitumor function.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2024, v. 43, n. 1, p. 1, doi. 10.1186/s13046-024-02985-1
- By:
- Publication type:
- Article